Walker & Dunlop WD
- Market cap
- $1.2B
- PE
- 30.5×
- 10y median 12.7×
- Forward PE
- n/m
- not a meaningful number
- Price to sales
- 0.9×
- EV/EBIT
- 26.3×
- Revenue, 12 months
- $1.3B
- +8% on a year ago
- Net margin
- 3.0%
- Free cash flow yield
- −11.2%
Walker & Dunlop trades at 30.5× trailing earnings, pricier than 89% of the last ten years. Revenue was $1.3B over the last twelve months, up 8% on a year earlier with a 3% net margin.
Charts
Financials
| Income statement | Q3 FY23 | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $268.7M−15% | $274.3M−3% | $228.1M−5% | $270.7M−1% | $292.3M+9% | $341.5M+25% | $237.4M+4% | $319.2M+18% | $337.7M+16% | $340M−0% | $301.3M+27% | $306.7M−4% | |
| $45.8M−28% | $58M−2% | $31.3M−37% | $46.1M−13% | $55.7M+22% | $68M+17% | $20.8M−34% | $63.1M+37% | $62.4M+12% | −$2.6M | $40.9M+97% | $17.3M−73% | |
| Interest expense | $17.6M+89% | $18.6M+54% | $17.7M+16% | $17.9M+5% | $18.2M+4% | $15.9M−14% | $15.5M−12% | $16.8M−6% | $16.5M−10% | $16M+0% | $14.9M−4% | $15.3M−9% |
| Pre-tax income | $28.2M−48% | $39.4M−17% | $13.7M−61% | $28.2M−22% | $37.5M+33% | $52.1M+32% | $5.2M−62% | $46.4M+65% | $45.9M+23% | −$18.6M | $25.9M+395% | $2.1M−96% |
| $7.1M−6% | $10.3M+8% | $2.9M−60% | $7.9M−25% | $8.8M+25% | $11M+6% | $2.5M−12% | $12.4M+57% | $12.5M+42% | −$5.4M | $8M+219% | −$764K | |
| Net income | $21.5M−54% | $31.6M−24% | $11.9M−56% | $22.7M−18% | $28.8M+34% | $44.8M+42% | $2.8M−77% | $34M+50% | $33.5M+16% | −$13.9M | $15.9M+476% | $3M−91% |
| $0.64−54% | $0.93−24% | $0.35−56% | $0.67−18% | $0.85+33% | $1.32+42% | $0.08−77% | $0.99+48% | $0.98+15% | −$0.41 | $0.46+475% | $0.09−91% | |
| 32.9M+1% | 32.9M+0% | 33M+1% | 33.2M+1% | 33.2M+1% | 33.2M+1% | 33.3M+1% | 33.4M+1% | 33.4M+1% | 33.4M+1% | 33.4M+0% | 33.3M−0% |
Operating income: 37 periods, Q2 FY10 to Q2 FY26: not printed by the filing, worked out from its own lines.
Net income: 12 periods, Q3 FY10 to Q3 FY13: not printed by the filing, worked out from its own lines.
EPS, diluted: 8 periods, Q4 FY10 to Q4 FY25: quarter's net income to common over its shares, to the cent.
Diluted shares: Q4 FY10 and Q4 FY25: a loss quarter: its basic count, share-days: the 12-month average less the 9-month, weighted by days. 14 periods, Q4 FY11 to Q4 FY24: share-days: the 12-month average less the 9-month, weighted by days.
From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.
Peers
Companies in Financial - Credit Services nearest Walker & Dunlop's size, closest first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| WDWalker & Dunlop | $1.2B | 30.5× | 12.7× | 0.9× | +8% | 3.0% | |
| JCAPJefferson Capital | $1.2B | 8.3× | 8.4× | 1.8× | +23% | 23.5% | |
| PWPPerella Weinberg Partners | $1.2B | 59.0× | 41.7× | 1.7× | −21% | 3.2% | |
| ATLCAtlanticus | $1.3B | 11.3× | 7.8× | 0.5× | +84% | 5.8% | |
| LQDTLiquidity Services | $1.4B | 44.0× | 30.6× | 2.9× | +5% | 6.8% | |
| NUTXNutex Health | $1.4B | 8.3× | 11.0× | 1.7× | +7% | 21.2% | |
| QNSTQuinstreet | $943.1M | n/m | 43.3× | 0.7× | +18% | n/m | |
| RHLDResolute Holdings Management | $934.6M | 22.0× | 20.9× | 0.8× | +159% | 4.2% | |
| PGYPagaya Technologies | $1.6B | 13.9× | 14.2× | 1.1× | +20% | 9.1% | |
| HAPNHappen | $1.6B | 8.5× | 20.6× | 1.6× | +18% | 18.7% | |
| PAYSPaysign | $842.4M | 57.4× | 52.5× | 8.4× | +47% | 15.7% | |
| Peer median | $1.2B | 13.9× | 20.8× | 1.6× | +19% | 9.1% |
More on Walker & Dunlop
Each number over time
- PE ratio
- Price to sales ratio
- EV/EBIT
- Price to free cash flow
- Price to book ratio
- Market cap
- Revenue
- EPS
- Free cash flow
- Profit margin
- Shares outstanding
Its groups
About
- Industry
- Financial - Credit Services
- Sector
- Financial Services
Valuation data, not investment advice. Prices as of .